Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Aug 20.
Published in final edited form as: Psychopharmacology (Berl). 2010 Nov 24;213(0):475–487. doi: 10.1007/s00213-010-2083-5

Social instigation and aggression in postpartum female rats: role of 5-Ht1A and 5-Ht1B receptors in the dorsal raphé nucleus and prefrontal cortex

Caroline Perinazzo da Veiga 1, Klaus A Miczek 2,3,4,5, Aldo Bolten Lucion 6, Rosa Maria Martins de Almeida 7,8,
PMCID: PMC3747518  NIHMSID: NIHMS482126  PMID: 21107539

Abstract

Rationale

5-HT1A and 5-HT1B receptor agonists effectively reduce aggressive behavior in males that has been escalated by social instigation. Important sites of action for these drugs are the receptors in dorsal raphé nuclei (DRN) and the ventral–orbital prefrontal cortex (VO PFC). DRN and VO PFC areas are particularly relevant in the inhibitory control of escalated aggressive and impulsive behavior.

Objectives

The objectives of this study are to assess the anti-aggressive effects of 5-HT1A (8-OH-DPAT) and 5-HT1B (CP-93,129) receptor agonists microinjected into DRN and VO PFC, respectively, and to study the aggressive behavior in postpartum female Wistar rats using the social instigation protocol to increase aggression.

Methods and Results

8-OH-DPAT (0.56 µg) in the DRN increased aggressive behavior in postpartum female rats. By contrast, CP-93,129 (1.0 µg) microinjected into VO PFC decreased the number of attack bites and lateral threats. 5-HT1A and 5-HT1B receptor agonists differed in their effects on non-aggressive activities, the former decreasing rearing and grooming and the latter increasing these acts. When 8-OH-DPAT was microinjected into DRN and CP-93,129 was microinjected into VO PFC in female rats at the same time, maternal aggression decreased. Specific participation of 5-HT1B receptors was verified by reversal of the anti-aggressive effects using the selective antagonist SB-224,289 (1.0 µg).

Conclusions

The decrease in maternal aggressive behavior after microinjections of 5-HT1B receptor agonists into the VO PFC and DRN of female postpartum rats that were instigated socially supports the hypothesis that activation of these receptors modulates high levels of aggression in a behaviorally specific manner, due to activation of 5-HT1B receptors at the soma and terminals.

Keywords: 8-OH-DPAT; CP-93, 129; Provocation; Female; 5-HT

Introduction

Postpartum aggression in female rodents represents a species-typical adaptation, and escalations beyond this level may model excessive aggression that is of clinical concern. In this sense, postpartum females were used as a model of naturally heightened aggression. In rats, maternal aggressive behavior occurs more frequently from days 3 to 12 after delivery, and during this period, females show intense care directed at the pups (Consiglio and Bridges 2009; Erskine et al. 1978).

In order to enhance the translational value, this type of aggression in postpartum females was escalated by social instigation to engender levels of aggression exceeding the normal species-typical responses. The social instigation procedure has proven to be a highly effective way to increase aggressive behavior in male animals by provoking or instigating a territorial resident through the close proximity of an opponent who cannot be attacked (Potegal 1991). The exposure of an experimental subject to a potential rival for a short time prior to the actual confrontation engenders intense levels of aggression, as originally described in mice (Lagerspetz and Hautojarvi 1967; Tellegen and Horn 1972). For example, male mice, rats, and hamsters initiate attacks with very short latency and at high frequency when tested with an intruder in their home cage or in an unfamiliar locale after having been provoked previously by an opponent (De Almeida and Miczek 2002; Fish et al. 1999; Potegal 1991). Instigation specifically increases aggressive behavior and does not activate locomotion, feeding, or sexual behavior (Lagerspetz and Hautojarvi 1967; Potegal and Tenbrink 1984; Potegal 1991). Even after removal of the instigating stimulus, high levels of aggression persist in fish and rodents, presumably from increased “aggressive arousal” or “attack readiness” (Potegal 1991). At the neurochemical level, male hamsters and rats that have been instigated to fight are characterized by a long-lasting decrease in serotonin in hypothalamus and in medial prefrontal cortex (Payne et al. 1984; van Erp and Miczek 2000). By contrast, behavioral and neurobiological information on escalated aggressive behavior by female animals is lacking.

The neural circuitry which is related to maternal aggressive behavior involves brain areas such as the periaqueductal gray matter, raphé nuclei, septal area, hypothalamic nuclei and ventral-orbital prefrontal cortex (De Almeida and Lucion 1997; Veiga et al. 2007; for review, see Lonstein and Gammie 2002), and several neurotransmitters are implicated in this type of behavior, prominently serotonin (De Almeida and Lucion 1994, 1997). Brain serotonin also plays a critical role in many impulsive types of aggressive behavior and violence in humans and other species (Caspi et al. 2009; Coccaro 1989; Garattini et al. 1967; Giacalone et al. 1968; Maas 1962; Valzelli 1981). The treatment options of escalated aggression are compromised by the fact that there are no selective pharmacotherapies, most still relying on antipsychotic medications (Volavka 1995, 2002).

Systemic administration of selective 5-HT1A receptor agonists such 8-OH-DPAT, alnespirone, S-15535 (De Boer et al. 2000; De Boer and Koolhaas 2005), and some specific 5-HT1B receptor agonists, such as CP-93,129 and CP-94,253 (De Almeida et al. 2006; Veiga et al. 2007; Bannai et al. 2007), exert efficacious and selective antiaggressive activity, both on species-typical and on escalated aggression when microinjected into VO PFC or dorsal raphé nucleus (DRN). On the other hand, some 5-HT1A receptor agonists, such as buspirone, flesinoxan, and ipsapirone, decrease aggressive behavior accompanied by undesirable side effects (De Almeida and Lucion 1994; Mos et al. 1992; Olivier et al. 1989a, b, 1990a, b, 1994). Escalated aggression and other types of aggressive behavior are effectively reduced by the stimulation of 5-HT1A and 5-HT1B receptors (De Almeida and Miczek 2002; De Almeida et al. 2006; Fish et al. 1999; Olivier and van Oorschot 2005; Veiga et al. 2007). Highly selective 5-HT1A and 5-HT1B receptor agonists do not significantly alter motor activities in the dose range that decreases aggressive behavior, both at species-typical (De Almeida and Lucion 1997; Joppa et al. 1997) and escalated levels (Centenaro et al. 2008; De Almeida and Miczek 2002; De Boer and Koolhaas 2005; Fish et al. 1999; Veiga et al. 2007). The specific role of these receptors was confirmed by reversal of the anti-aggressive effects using selective 5-HT1A and 5-HT1B antagonists WAY-100,635 and SB-224,289 (Centenaro et al. 2008; De Almeida et al. 2006; De Boer et al. 1999, 2000; Lopez-Mendoza et al. 1998; Miczek et al. 1998).

5-HT1A receptors are located on somata and dendrites in the DRN, where they act as inhibitory autoreceptors (Miquel et al. 1992). The 5-HT1A receptors are also located postsynaptically in limbic areas acting as heteroceptors on non-serotonergic neurons, where they inhibit the release of other neurotransmitters (Barnes and Sharp 1999). The 5-HT1B receptors are located pre- and postsynaptically, the former act as autoreceptors on serotonergic terminals (Boschert et al. 1994; Bonaventura et al. 1998) and the latter are located as heteroreceptors. The prefrontal cortex is a brain region that contains both 5-HT1A and 5-HT1B receptors, specifically in the ventral–orbital region, and this area has been identified as a particularly important site in the inhibitory control of the sub-cortical circuits mediating aggressive and impulsive behavior (Blair 2001, 2004; Séguin 2004; Cardinal et al. 2004; Kheramin et al. 2005; Veiga et al. 2007). Violent behavior is found in patients with lesions or neurodegenerative disorders in areas of the PFC, suggesting that this area is critical for the control of aggressive behavior (Hawkins and Trobst 1998, 2000; Davidson et al. 2000; Veit et al. 2002; Blair 2004; for review, see Brower and Price 2001).

Initially, we tested the hypothesis that 5-HT1B receptors in serotonergic terminals are critical in the VO PFC for the control of escalated aggressive behavior in postpartum females. To this end, we examined the antiaggressive effects of the 5-HT1B receptor agonist, CP-93,129, after this compound was microinjected into the VO PFC. A further test of this hypothesis was to confirm the specificity of 5-HT1B receptor site as critical for decreasing aggressive behavior by microinjecting the 5-HT1B receptor antagonist SB-224,289 into the VO PFC. We expanded the hypothesis by integrating actions at terminal and somatodendritic receptors as sites of action for the behavioral effects of the receptor 5-HT1A and 5-HT1B agonists, respectively, by microinjecting 8-OH-DPAT into the DRN and CP-93,129VO PFC at the same time. Finally, we sought to determine whether the anti-aggressive effects were the result of activation of pre- or postsynaptic receptors (5-HT1A or 5-HT1B).

Materials and methods

Animals

Nulliparous female Wistar rats (N=114), born and bred at Universidade do Vale do Rio dos Sinos, UNISINOS, 3–4 months old and weighing between 250 and 350 g, were maintained on a 12:12-h light:dark cycle, lights on at 4:00 am. After delivery, each litter was culled to eight pups. To test maternal aggressive behavior, the experimental female rats confronted male Wistar rats. Each male intruder was used only once per behavioral test. Females were kept in polycarbonate cages (65×55×25 cm). Intruders were male rats which had a direct confrontation with the residents (n=60) and weighed on average 50 g less than the females. The instigators were the animals that were protected and did not have a direct confrontation with the residents (n=60); they were also on average 50 g smaller than the resident females, and were maintained in groups of five, in standard polycarbonate cages (65×55× 25 cm). The instigators were males that were never used as intruders. All of the rats were from the same strain, and all rats were kept in the same room in a temperature-controlled environment (20±2°C) with food and water available ad libitum.

Resident intruder confrontation

On the third postpartum day, females were selected for maternal aggressive behavior and only those displaying more than two bites against an unprotected intruder during a 10-min confrontation were used as subjects. About 30% of females were excluded because they did not meet this criterion. The behavioral test was conducted in the home cage of the female residents. From postpartum days 3 to 12, a high level of aggression is observed in females, and thereafter, aggressive behavior declines (Erskine et al. 1978; Mos and Olivier 1986).

Social instigation

On the fifth postpartum day, the social instigation procedure was implemented. The social instigation consisted of placing a clear perforated glass cylinder (28 cm long, 10 cm in diameter) containing an opponent male (“instigator”), for 5 min in the center of the female resident’s home cage. The residents typically threatened the protected instigator and attacked the perforated glass cylinder. In general, rodents initiate attacks with very short latency and high frequency when tested with an intruder in their home cage after having been provoked previously by an opponent (Potegal 1991). The pups remained inside the cage together with their dams during the social instigation and the confrontation with the intruder.

Surgery

On the sixth postpartum day, each female was anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine intra-peritoneally (IP), placed in a stereotaxic frame (David Kopf; Tujunga, CA, USA), and implanted with one or two guide cannulae (22 gauge) fixed with dental cement to the skull. One cannula was aimed at the VO PFC at the right hemisphere: 4.3 mm anterior to bregma, 0.6 mm lateral to the mid-saggital line, 2.1 mm below dura mater. A second cannula was aimed at the DRN at the right hemisphere: −7.8 mm posterior to bregma, 1.6 mm lateral to the mid-saggital line, 5.2 mm below dura mater, tilted in a 20° angle. The coordinates were based on the atlas by Paxinos and Watson (1998). Females remained separated from the pups for 2 h. Experiments were performed in accordance with the current NIH Guide for Animal Care and Use and Colégio Brasileiro de Exper-imentação Animal (COBEA), and they were approved by the Research Committee of the University.

Microinjections

On the ninth postpartum day, the microinjections with agonist and antagonist or vehicle were performed 15 and 30 min before the resident–intruder test, respectively (Veiga et al. 2007). The naive male intruder was placed into the female’s cage, and immediately thereafter, the behaviors were videotaped for 10 min. The solutions were slowly infused over the course of 60 s at a rate of 0.2 µl/min, using a Hamilton syringe connected by tubing to the injecting needle that stayed in situ for a further minute after the microinjection.

Experimental groups:

Experiment 1: The animals were microinjected with CP-93,129 at 0.56 µg/0.2 µl (n=12) or vehicle (saline) (n=9) into the VO PFC 15 min before the confrontation with the intruder.

Experiment 2 The females received two microinjections into the VO PFC. First, the animals were micro-injected with 5-HT1B receptor antagonist, SB-224,289 (5.0 µg/0.2 µl) and 15 min later with the 5-HT1B receptor agonist, CP-93,129 (1.0 µg/0.2 µl) (n=12) or vehicle (n=13) or with vehicle plus vehicle (n=12).

Experiment 3 The animals were microinjected with a 5-HT1A receptor agonist, 8-OH-DPAT (0.56 µg/0.2 µl) into DRN and with a 5-HT1B receptor agonist, CP-93,129 (0.1 and 1.0 µg/0.2 µl, n=9) into VO PFC or vehicle and vehicle into DRN and into VO PFC. Both microinjections were performed immediately following each other. The control groups were microinjected with saline. In sequence, the rat was microinjected with 8-OH-DPAT immediately followed by CP-93,129. The behavioral tests occurred 15 min after the microinjections.

The groups studied were as follows:

  • Vehicle into DRN + vehicle into VO PFC (n=11) Vehicle into DRN + CP-93,129 (1.0 µg/0.2 µl) into VO PFC (n=10)

  • 8-OH-DPAT (0.56 µg/0.2 µl) into DRN + vehicle VO PFC (n=9)

  • 8-OH-DPAT (0.56 µg/0.2 µl) into DRN + CP-93,129 (0.1 µg/0.2 µl) into VO PFC (n=9)

  • 8-OH-DPAT (0.56 µg/0.2 µl) into DRN + CP-93,129 (1.0µg/0.2 µl) into VO PFRC (n=9)

Drugs

CP-93,129 (1,4-dihydro-3-[1,2,3,6-tetrahydro-4-pyridinyl]-SH-pyrrolo [3,2-b] pyridine-5-one dihydrochloride; Pfizer, Groton, CT, USA), and 8-OH-DPAT (8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide; Sigma, St. Louis, MO, USA) were dissolved and sonicated in saline solution. The 5-HT1B receptor agonist, CP-93,129 was donated by Pfizer.

Histology

After completion of all behavioral tests, the dams were deeply anesthetized with an overdose of sodium thiopental. Brains were perfused with saline and thereafter with 4% formaldehyde. The brains were removed and fixed in 4% formaldehyde and later cut on a vibratome in 50-micron coronal slices. Locations of the cannula tips were determined via microscopic analysis, and only the animals with an exact localization were used for data analysis (Fig. 1). The animals that were designated as anatomical controls had incorrectly positioned placements. Histological analysis showed that 66 cannula placements were correctly positioned in the target areas in experiments 1 and 2 (Fig. 2), and 48 cannula placements were correctly positioned in the target areas in experiment 3 (Fig. 3). Five animals were anatomical controls in experiment 1 (Fig. 2a), seven in experiment 2 (Fig. 2b), and eight in experiment 3 (Fig. 3a, b).

Fig. 1.

Fig. 1

a Photomicrograph showing the placement of the guide cannula and injection in the VO PFC. b Photomicrograph showing the placement of guide cannula and injection into DRN (arrow)

Fig. 2.

Fig. 2

a, b Schematic representation of successive coronal sections of the rat brain showing the histological verification of injection placement (n=66) in the ventral–orbital prefrontal cortex (rostral to caudal: 5.20, 4.70, 4.20, and 3.70 mm anterior to the bregma). VO ventral–orbital frontal cortex, LO lateral orbital cortex, MO medial orbital cortex, Cg3 cingulate cortex, area 3, Fr2 frontal cortex, area 2, AI agranular insular cortex, VLO ventrolateral orbital cortex. All the images are from Paxinos and Watson (1998). a Experiment 1: Asterisks represent the site of CP-93,129 injection and pen circles represent the site of vehicle injection. b Experiment 2: Asterisks represent the site of SB-224,289 injection and pen circles represent the site of vehicle injection. Diamonds represent off-target injections for CP-93,129, vehicle, or SB-224,289 injections

Fig. 3.

Fig. 3

Experiment 3. a Schematic representation of successive coronal sections of the rat brain showing the histological verification of injection placement (n=48) in the ventral–orbital frontal cortex (rostral to caudal: 5.20, 4.70, 4.20, and 3.70 mm anterior to the bregma). VO ventral–orbital frontal cortex, LO lateral orbital cortex, MO medial orbital cortex, Cg3 cingulado cortex, area 3, Fr2 frontal cortex, area 2, AI agranular insular cortex, VLO ventrolateral orbital cortex. Asterisks represent the site of CP-93,129 injection and pen circles represent the site of vehicle injection. b Schematic representation of successive coronal sections of the rat brain showing the histological verification of injection placement (n=48) in the dorsal raphé nucleus (rostral to caudal: −7.04, −7.30, −7.64, −7.80, −8.00, −8.30, −8.72, and −8.80 mm posterior to the bregma). CG central gray, 3PC oculomotor nucleu parvocellular, Su3 supraoculomotor central gray, mlf medial longitudinal fasciculus, CLi caudal linear nucleu raphé, CGLV central gray, lateral ventral, CGM central gray medial, Me5 mesencephalic trigeminal nucleu. Asterisks represent the site of 8-OH-DPAT injection and pen circles represent the site of vehicle injection. Diamonds represent no target of CP-93,129, vehicle or 8-OH-DPAT injections. All the images are from Paxinos and Watson (1998)

Behavioral analysis

The resident–intruder confrontations were videotaped and later analyzed by a trained investigator with adequate inter-and intra-observer reliability using The Observer software (version 3.0, Noldus, The Netherlands). De Almeida and Lucion (1997) previously defined the behavioral repertoire of lactating females, including the frequency and duration of aggressive elements such as lateral threat, lateral attack, bite, and pin, and the duration of non-aggressive elements such as sniffing the intruder, grooming, rearing, and walking. Pup care measurements included how long each dam carried, licked, and nursed the pups.

Statistical analysis

After confirming the homogeneity of variance of all data, they were expressed as mean ± SEM. The effect of social instigation on maternal aggressive behavior was analyzed using a paired Student t test, comparing species-typical baseline aggression vs aggression after social instigation.

Data from all three experiments were analyzed using one-way ANOVAs. When a statistically significant F value (p<0.05) was obtained, Newman–Keuls post hoc tests were conducted comparing drug treatments with the corresponding vehicle group. Regarding non-aggressive motor behaviors, the data from all groups with agonist and antagonist treatment were compared with those from their respective controls using ANOVA. When significant differences were found, Newman–Keuls post hoc tests were performed. The data from the anatomical control animals were compared to those from the vehicle group using a paired Student t test.

Results

Heightened aggression after social instigation

Social instigation significantly increased bite frequency in postpartum female rats compared to a non-instigated control group (t (104)=2.87; p<0.004; Fig. 4).

Fig. 4.

Fig. 4

The effects of instigation (Inst) by an intruder on maternal aggressive behavior in resident female rats (N=105 in each group). The aggressive behavior portrayed is the frequency of attack bites towards the male intruder under control (Ctrl) and instigation (Inst) conditions. Vertical bars represent the mean ± SEM. Asterisk, p≤0.004

Aggressive behaviors

In experiment 1, CP-93,129 (1.0 µg) microinjected into VO PFC of instigated females decreased the frequency of lateral attack (F(5,77)=4.78; p<0.008; Table 1), lateral threat (F (3,33)=3.62; p<0.05; Table 1), and pinning the intruder (F (5,16)=3.98; p<0.01; Table 1) as compared to the control group. The 1.0 µg dose decreased the frequency of lateral attack as compared to 0.56 µg (F(5,77)=3.03; p<0.08; Table 1). The lower dose of CP-93,129 (0.56 µg) decreased only the frequency of pinning the intruder (F(5,16)=3.93; p< 0.01; Table 1) as compared to the control group. The duration (in seconds) of lateral attack (F(5,95)=4.86; p<0.007; Table 1), lateral threat (F(3,34)=3.65; p<0.05; Table 1), and pinning the intruder (F(4,66)=4.07; p<0.01; Table 1) decreased when CP-93,129 (1.0 µg) was microinjected into VO PFC, as compared to the control group. The lower dose of CP-93,129 (0.56 µg) decreased the duration of pinning the intruder (F(4,66)=3.34; p<0.01; Table 1) as compared to the control group. When CP-93,129 was microinjected at the 1.0 µg dose outside of the VO PFC, it did not alter any of the aggressive behaviors (Table 1).

Table 1.

Behaviors during aggression in postpartum female rats

Parameter CP-93,129 doses (µg/0.2 µl)
Vehicle SB-224,289 (5.0 µg/0.2 µ1)
Ac
Vehicle
(n=9)
0.56 (n=12) 1.0 (n=8) Ac (n=5) +Vehicle
(n=12)
+Vehicle
(n=13)
+CP-93,129
(n=12)
(n=7)
Latency to attack 28.0±7.4 76.4±11.1b 21.5±12.2a 52.3±9.6 86.0±21.0 64.7±21.3 68.6±31.5 44.6±18.7
Frequency
  Lateral attack 12.0±2.4 8.3±1.5 2.7±1.1c 9.8±3.6 8.5± 1.3 5.5±1.0 10.2± 1.8 10.0±4.9
  Bite the body 4.6±2.1 3.5 ±1.1 2.0±1.1 5.6±4.2 1.4±0.8 2.1 ±0.8 2.0±0.6 3.1 ±2.0
  Lateral threat 6.1±1.7 4.2±1.2 0.9±0.5d 6.4±2.9 1.2±0.4 2.2±0.7 2.8±0.8 5.0±3.4
  Pin 4.6±1.1 1.4±0.9 d 0.1 ±0.1 d 2.2±1.5 0.2±0.2 0.1 ±0.1 0.9±0.4 0.8±0.4
Duration aggressive behaviors
  Lateral attack 9.30±1.98 5.35±1.27 1.76±0.7 d 7.84±3.21 6.17± 1.34 4.04±0.86 7.49±1.65 7.77±4.11
  Bite the body 3.82± 1.81 2.19±0.75 1.87±0.93 6.24±5.57 0.81 ±0.46 1.26±0.53 1.05±0.35 3.50±2.51
  Lateral threat 10.02±2.83 6.06±2.24 1.21 ±0.81d 18.42±8.35 2.60±1.03 3.36± 1.33 4.55±1.53 9.68±7.31
  Pin 20.71±7.02 5.89±3.56 0.81 ±0.81c 9.50±5.85 0.80±0.80 0.32±0.24 4.27±2.61 1.80±0.90
Duration non agressive behaviors
  Sniffing 170.4±30.6 160.2±13.8 84.2±20.7c 246.3±35.6 194.2±17.8 185.1 ± 17.3 203.2±28.8 214.6±35.3
  Pup care 6.9±4.0 1.4±0.8 16.3±10.5 4.1 ±1.9 1.7±0.9 1.9± 1.4 1.8±1.4 2.6±1.3
  Walking 98.4±14.5 138.6±17.5 91.6±12.3 95.9± 10.1 85.0±13.9 113.3±9.8 135.3±8.9f 107.6±16.3
  Rearing 11.5±5.5 21.0±3.6 43.4±14.0d 19.62±4.0 11.1 ±3.0 29.4±6.8g 12.6±2.3 6.9±2.3
  Grooming 53.3±13.0 69.9±14.2 37.2±10.8 59.1 ±20.6 44.0±14.7 59.5±12.2 43.4±8.0 56.2±15.0

Data expressed in mean ± SEM

Ac anatomical controls

a

p<0.01, compared to 0.56 group

b

p<0.01, compared to vehicle group

c

p<0.05, compared to vehicle and 0.56 groups

d

p<0.05, compared to vehicle group

e

p<0.05, compared to veh + veh and SB + vehicle group

f

p<0.01, compared to veh + veh group

g

p<0.01, compared to veh + veh and SB + CP group

In experiment 2, the pretreatment with the 5-HT1B receptor antagonist, SB-224,289, at the 5.0 µg dose antagonized the decrease of frequency of lateral threat and pinning the intruder produced by CP-93,129 (Table 1). The frequency of lateral attacks was not altered as compared to control group (Table 1). There were no significant effects on aggressive behaviors after the microinjections of vehicle and SB-224,289 into VO PFC (Table 1). The duration (in seconds) of lateral threat and pinning the intruder produced by CP-93,129 too was antagonized after the pretreatment with the 5-HT1B receptor antagonist, SB-224,289 at the 5.0-µg dose (Table 1). The duration of lateral attacks was not altered as compared to control group (Table 1).

In experiment 3, microinjections of 8-OH-DPAT at the 0.56 µg dose into the DRN followed by vehicle into VO PFC significantly increased the frequency (F(3,45)=4.13; p< 0.01, Fig. 5a) and the duration (F(3,48)=4.06; p<0.01, Fig. 5a) of lateral attacks as compared to the vehicle group. Microinjections of 8-OH-DPAT into DRN (0.56 µg) followed by vehicle into the VO PFC also increased the frequency (F(3,34)=3.50; p<0.01, Fig. 5b) and the duration (F(3,32)=3.56; p<0.01, Fig. 5a) of bites directed at the intruder’s body as compared to vehicle group. By contrast, microinjections of 8-OH-DPAT into the DRN (0.56 µg) followed by CP-93,129 (1.0 µg) into VO PFC decreased the frequency (F(3,45)=4.89; p<0.01; Fig. 5a, b) and the duration (F(3,48)=4.97; p<0.01, Fig. 5a, b) of lateral attacks and also decreased the frequency (F(3,34)=4.63; p<0.01; Fig. 5a, b) and the duration (F(3,32)=4.58; p<0.01, Fig. 5a) of bites directed at the intruder’s body as compared to 8-OH-DPAT (0.56 µg) + vehicle. The frequency and the duration of lateral threats was not changed in any of the groups after microinjections of 8-OH-DPAT + vehicle or 8-OH-DPAT (0.56 µg) + CP-93,129 (0.1 µg) or 8-OH-DPAT (0.56 µg) + CP-93,129 (1.0 µg) (see Table 2).

Fig. 5.

Fig. 5

Effects of 5-HT1A receptor agonist 8-OH-DPAT in the dorsal raphé nucleus and of 5-HT1B receptor agonist CP-93,129 in the VO PFC on escalated aggressive behavior. a Frequency of lateral attacks. a p≤0.05 compared to Veh + Veh; c p≤0.05 compared to 8-OH + Veh. b Frequency of bites, directed at the body of the intruder after vehicle microinjection followed immediately by a second vehicle, vehicle followed immediately by CP-93,129 (1.0 µg/0.2 µl), 8-OH-DPAT (0.56 µg/0.2 µl), followed immediately by vehicle, 8-OH-DPAT (0.56 µg/0.2 µl) followed immediately by CP-93,129 (0.1/0.2 µl), and 8-OH-DPAT (0.56 µg/0.2 µl) followed immediately by CP-93,129 (1.0 µg/0.2 µl), respectively. abe p≤0.05 compared to Veh + Veh; Veh + CP 1.0 and 8-OH+CP 1.0. Vertical bars represent the mean ± SEM

Table 2.

Behaviors during aggression in postpartum female rats

Parameter Vehicle
8-OH [0.56]
Ac
+ Vehicle
(n=11)
+ CP-93 [1.0]
(n=10)
+ Vehicle (n=9) + CP-93 [0.1]
(n=9)
+ CP-93 [1.0]
(n=9)
(n=8)
Latency to attack 97.8±40.3 48.0±14.9 52.0±13.0 71.4±29.4 47.1 ±26.0 26.4±12.5
Frequency
  Lateral attack 6.8±2.0 9.4±2.3 17.5±4.1b 8.2±2.4 4.2±1.8a 11.6±3.8
  Bite the body 3.7±1.2 2.3±0.7a 9.6±3.0b 4.8±1.9 1.4±0.6a 10.5±4.1
  Lateral threat 1.4±0.8 1.2±1.0 2.5±1.4 1.6±1.1 1.5±0.8 1.5± 1.2
Duration aggressive behaviors
  Lateral attack 5.01 ±1.61 7.47±2.05 14.14±3.90b 6.45±2.04 2.42±1.09c 9.12±3.28
  Bite the body 2.66±0.99 1.54±0.57a 7.46±2.59 3.46±1.37 0.97±0.44a 8.25±3.57
  Lateral threat 1.31 ±0.87 1.51 ±1.40 4.96±3.21 2.38±1.88 5.86±4.05 1.50±1.23
Duration non aggressive behaviors
  Walking 103.4±12.4 91.3±14.4 87.8±15.0 132.0±30.5 139.6±21.9 102.1 ±24.0
  Sniffing 199.8±17.8 212.4±27.2 238.0±21.4 180.7±21.9 172.7±28.0 155.8±29.3
  Pup care 20.9±14.0 3.2±1.9 30.5±28.3 29.9±29.5 8.3±6.3 97.7±50.0
  Rearing 16.0±4.6 4.5± 1.1 15.6±4.2 13.2±6.4 16.5±6.9 8.4±2.7
  Grooming 53.1 ± 13.1 77.4±8.8 57.4±13.6 84.4±20.3 49.5±9.7 52.3±19.1

Data expressed in mean ± SEM

Ac anatomical controls

a

p<0.05, compared to 8-OH + Veh group

b

p<0.05, compared to Veh + Veh group

c

p<0.01, compared to 8-OH + Veh group

Non-aggressive behaviors

In experiment 1, microinjection of 1.0 µg CP-93,129 into VO PFC significantly decreased the duration of sniffing the intruder and the duration of rearing when compared to the control group. The other behaviors, such as interacting with pups, walking, and grooming, were not altered by any dose of CP-93,129 (Table 1).

In experiment 2, only the duration of rearing was decreased after the microinjection of SB-224,289 plus vehicle as compared to this measure in the control group (Table 1). The treatment with SB-224,289 + CP-93,129 changed the duration of non-aggressive behaviors such as walking and rearing as compared to SB-224,289 + vehicle. All the other non-aggressive behaviors remained unchanged as compared to the measures in the control group (Table 1).

In experiment 3, none of the non-aggressive behaviors, such as walking, rearing, and grooming, were changed by the microinjections of 8-OH-DPAT into the DRN and CP-93,129 into the VO PFC (Table 2).

Discussion

The current experiments provide evidence that stimulation of the 5-HT1A somatodendritic autoreceptors in the DRN via the agonist 8-OH-DPAT significantly increases aggressive behavior by postpartum females, while activation of 5-HT1B receptors in the VO PFC has anti-aggressive effects. The current study is the first to demonstrate increased aggressive behavior in postpartum females with microin-jection of 8-OH-DPAT in the DRN after social instigation. Moreover, this appears to be the first evidence for functionally opposing roles of receptor subtypes within the 5-HT1 family, at least with regard to aggressive behavior by postpartum females.

Contrary to the aggression-escalating effects in the present experiments after 8-OH-DPAT microinjection into the DRN, 8-OH-DPAT and alnespirone microinjections into the DRN diminished aggressive behavior in male rats (Mos et al. 1993). De Almeida and Lucion (1997) microinjected 8-OH-DPAT (0.2 and 2.0 µg) directly into the median raphé nucleus and found a decrease in aggression during the postpartum period of female Wistar rats. By contrast, microinjection of 8-OH-DPAT (0.2–2.0 µg) into the medial septal area increased postpartum aggressive behavior (De Almeida and Lucion 1997).

8-OH-DPAT increased important elements of aggressive behavior by postpartum females due to action on serotonergic neurons in the DRN; it causes an auto-inhibition via action on the 5-HT1A autoreceptors (Sprouse and Aghajanian 1987). The activation of 5-HT1A receptors by 5-HT leads to an opening of potassium channels causing a hyperpolarization (Sprouse and Aghajanian 1987) and inhibition of the impulse flow in serotonergic cells (Sinton and Fallon 1988; Sprouse and Aghajanian 1986, 1987; Vandermaelen et al. 1986) and the release of 5-HT in terminal areas (Adell et al. 1993; Bosker et al. 1994; Casanovas et al. 1997; Kreiss and Lucki 1994; Sharp et al. 1989), including the prefrontal cortex. In particular, 5-HT1A autoreceptors on DRN show an important role in the physiologic control by ascending serotonergic pathways, attenuation of the excessive activation from 5-HT neurons by excitatory afferences from various structures in the brainstem (Descarries et al. 1982; Jacobs and Azmitia 1992; Baumgarten and Grozdanovic 1997; Ferreira and Menescal-de-Oliveira 2009). Using the current microinjection technique, it is likely that, with the 8-OH-DPAT-induced diminished impulse flow of serotonin to the prefrontal cortex, CP-93,129 diminished aggressive behavior by acting primarily presynaptically.

By contrast, CP-93,129 reduced the offensive elements of maternal aggressive behavior such as the frequency of lateral attacks and the number of bites directed toward the intruder’s body (Haney et al. 1989), as well as the duration of lateral attacks and bites (Table 1). On the other hand, no changes were detected in the defensive nature of the female’s response, most prominently quick frontal attacks, which have been interpreted most often in terms of a fear or anxiety response towards the intruder (De Almeida and Lucion 1997; Neumann et al. 2010). Our previous studies have also demonstrated that CP-93,129 primarily modifies the offensive elements of maternal aggression (Veiga et al. 2007). The 5-HT1B receptor agonist CP-93,129 reduced maternal aggressive behavior at the highest dose (1.0 µg), and even at the lower 0.1-µg dose had a tendency to decrease the maternal aggressive behavior when micro-injected into the VO PFC. The two vehicle microinjections plus CP-93,123 did not have the same effects on the socially instigated lactating females, which also received two instead of one microinjection. All animals received two injections, a potentially more stressful procedure. Interference with aggressive behavior due to this more stressful procedure is another possibility to explain the differential outcomes in the studies from Veiga et al. (2007) and the present one (see De Castilhos et al. 2006; Padovan and Guimarães 2004). Also, seasonal and between-group variability could have accounted for this difference since the two experiments were performed several months apart, confirming earlier observations (Padovan and Guimarães 2004). This anti-aggressive effect was particularly evident in the experimental group that showed very high levels of aggressive behavior after microinjection of 8-OH-DPAT (0.56 µg) in the DRN followed immediately by the microinjection of CP-93,129 (1.0 µg) into the VO PFC, and as detected by the duration of lateral attacks and bites of the intruder’s body (Table 2). However, a significant decrease in aggression was evident in the group microinjected with vehicle followed by CP-93,129 (1.0 µg) into VO PFC. This decrease was significant for the measures of lateral attacks, attack bites, and lateral threats. The non-aggressive behaviors such as locomotion and social investigation were not altered, providing further evidence for the behavioral specificity of the role of 5-HT1B receptors in the modulation of maternal aggressive behavior. CP-93,129 and SB-224,289 are compounds with high affinity for the 5-HT1B receptor (pKi =8.1 and pKi =8.2, respectively), when compared with other subtypes of the 5-HT1 receptor family (Centenaro et al. 2008; Roberts et al. 2001). Systemic or intracerebral administration (Bannai et al. 2007; Centenaro et al. 2008; De Boer and Koolhaas 2005) of CP-93,129 have been shown to exert potent anti-aggressive effects, without modifying other types of non-aggressive behavior.

The relatively few studies on neural mechanisms mediating maternal aggressive behavior (Consiglio et al. 2005; De Almeida and Lucion 1997; Factor et al. 1993; Ferreira et al. 1987; Hansen and Ferreira 1986, Giovenardi et al. 1998; Insel 1986; Lonstein and Gammie 2002; Nelson and Trainor 2007; Russel and Leng 1998; Svare 1990) implicate the mediodorsal region of the thalamus, peripe-duncular nucleus of the lateral midbrain (PPN), septum, paraventricular and medial hypothalamus, and amygdala. The defensive nature of the postpartum female’s response, most prominently frontal attacks, has been interpreted most often in terms of a fear or anxiety response towards the intruder. Previously, we showed that the 5-HT1B receptors in the VO PFC have an important role in maternal aggressive behavior (Veiga et al. 2007).

The respective roles of 5-HT1A and 5-HT1B receptors in modulating aggressive behavior remain a source of debate and conflicting evidence (De Almeida and Lucion 1997; Millan et al. 1997; Mos et al. 1993; Sanchez and Hyttel 1994; Sijbesma et al. 1991). Consistent with the present results, there is evidence that the anti-aggressive effects of 5-HT1A receptor stimulation are caused via activation of the 5-HT postsynaptic receptors (Sijbesma et al. 1991; Mos et al. 1992, 1993; Olivier and van Oorschot 2005). Microinjections of CP-93,129 or CP-94,253 into the DRN exert potent anti-aggressive effects, which can be obtained by action at multiple sites, somatodendritic autoreceptors, presynaptic terminal autoreceptors, and postsynaptic heteroreceptors (Bannai et al. 2007; Faccidomo et al. submitted). Studies with 5-HT1B full and partial receptor agonists such as CP-94,253, eltoprazine, TFMPP, zolmitriptan, and anpirtoline have consistently shown anti-aggressive effects, regardless of the basal levels of aggressive behavior (De Almeida and Miczek 2002; Miczek et al. 2002; Mos et al. 1992; Olivier and Mos 1986), which can be mediated by somatodendritic autoreceptors (Bannai et al. 2007, Faccidomo et al. submitted) or postsynaptic heteroreceptors (De Almeida et al. 2001).

However, some studies emphasize 5-HT1A autoreceptors as the relevant site for the antiaggressive effects of BMY-7378 (White et al. 1991), NAN-190 (Sanchez et al. 1996), and, particularly, S-15535 (De Boer and Koolhaas 2005; Millan et al. 1997). Other studies have shown that maternal aggressive behavior in rats was decreased after systemic administration of 5-HT1A receptor agonists such as ipsapir-one, 8-OH-DPAT, fluprazine, and buspirone and by DOI, a5-HT2A/C receptor agonist (Ferreira et al. 2000; Lonstein and Gammie 2002; Olivier et al. 1985, 1986, 1995), and by the SSRI fluvoxamine (Lonstein and Gammie 2002).

In summary, CP-93,129, when microinjected into the region of the VO PFC of postpartum female rats that were provoked socially, acting either on presynaptic terminal 5-HT1B autoreceptors or on postsynaptic heteroreceptors, reduced aggressive behavior. On the other hand, the activation of the somatodendritic 5-HT1A autoreceptors via the local microinjection of 8-OH-DPAT into the DRN increased aggressive behavior in postpartum female rats. It is possible that 5HT1B receptors in VO PFC participate in enhancing maternal responsivity, including maternal aggression and pup care, rather than aggression itself. On the other hand, the defensive nature of the female’s response, most prominently frontal attacks, may involve fear or anxiety responses towards the intruder, contrasting with pup care (Table 1).

Further experiments are necessary to assess the role of 5-HT1A and 5-HT1B receptor agonists in the DRN and in the VO PFC, respectively in male aggression to assess potential sex differences in rodents and primate species. As complement to the current neuropharmacological studies of the VO PFC and the DRN, we are currently assessing the activation of neurons in these areas as indicated by c-Fos during an aggressive confrontation in female rats (Veiga et al. in preparation). Furthermore, it is important to learn to what extent social instigation induces genomic and non-genomic changes in 5-HT1A or 5-HT1B receptor expression.

Contributor Information

Caroline Perinazzo da Veiga, Programa de Pós-Graduação em Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Klaus A. Miczek, Department of Psychology, Tufts University, Medford and Boston, MA, USA Department of Pharmacology, Tufts University, Medford and Boston, MA, USA; Department of Neuroscience, Tufts University, Medford and Boston, MA, USA; Department of Psychiatry, Tufts University, Medford and Boston, MA, USA.

Aldo Bolten Lucion, Departamento de Fisiologia, Programa de Pós-Graduação em, Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.

Rosa Maria Martins de Almeida, Email: rosa_almeida@yahoo.com, rosa.almeida@ufrgs.br, Instituto de Psicologia do Desenvolvimento e da Personalidade da, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil; Laboratório de Psicologia Experimental, Neurociências e Comportamento, Porto Alegre, Rio Grande do Sul, Brazil.

References

  1. Adell A, Carceller A, Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem. 1993;60:1673–1681. doi: 10.1111/j.1471-4159.1993.tb13390.x. [DOI] [PubMed] [Google Scholar]
  2. Bannai M, Fish EW, Faccidomo S, Miczek KA. Antiaggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of mice. Psychopharmacology. 2007;193:295–304. doi: 10.1007/s00213-007-0780-5. [DOI] [PubMed] [Google Scholar]
  3. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083–1152. doi: 10.1016/s0028-3908(99)00010-6. [DOI] [PubMed] [Google Scholar]
  4. Baumgarten HG, Grozdanovic Z. Anatomy of central serotonergic projection systems. In: Baungarten HG, Gothert M, editors. Serotonergic Neurons and 5-HT Receptors in the CNS. Berlin: Springer; 1997. pp. 41–71. [Google Scholar]
  5. Blair RJ. Neurocognitive models of aggression, the antisocial personality disorders, and psychopathy. J Neurol Neurosurg Psychiatry. 2001;71:727–731. doi: 10.1136/jnnp.71.6.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blair JR. The roles of orbital frontal cortex in the modulation of antisocial behavior. Brain Cogn. 2004;55:198–208. doi: 10.1016/S0278-2626(03)00276-8. [DOI] [PubMed] [Google Scholar]
  7. Bonaventura P, Voorn P, Luyten WHML, Jurzak M, Schotte A, Leyten JE. Detailed mapping of serotonin 5-HT1B and 5-HTlD receptor messenger RNA and ligand binding sites in guinea pig brain and trigeminal ganglion: clues for function. Neuroscience. 1998;82:469–484. doi: 10.1016/s0306-4522(97)00302-3. [DOI] [PubMed] [Google Scholar]
  8. Boschert U, Amara DA, Segu L, Hen R. Then mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience. 1994;58:167–182. doi: 10.1016/0306-4522(94)90164-3. [DOI] [PubMed] [Google Scholar]
  9. Bosker F, Klompmakers A, Westenberg H. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2- (Di-n -Propylamino) tetralin and is sensitive to tetrodotoxin. J Neuro-chem. 1994;63:2165–2171. doi: 10.1046/j.1471-4159.1994.63062165.x. [DOI] [PubMed] [Google Scholar]
  10. Brower MC, Price BH. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: a critical review. J Neurol Neurosurg Psychiatry. 2001;71:720–726. doi: 10.1136/jnnp.71.6.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cardinal RM, Winstanley CA, Robbins TW, Everitt BJ. Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci. 2004;1021:33–50. doi: 10.1196/annals.1308.004. [DOI] [PubMed] [Google Scholar]
  12. Casanovas JM, Lésourd M, Artigas F. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br J Pharmacol. 1997;122:733–741. doi: 10.1038/sj.bjp.0701420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science. 2009;297:851–854. doi: 10.1126/science.1072290. [DOI] [PubMed] [Google Scholar]
  14. Centenaro LA, Vieira K, Zimmermann N, Miczek KA, Lucion AB, De Almeida RMM. Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex. Psychopharmacology. 2008;201:237–248. doi: 10.1007/s00213-008-1269-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Coccaro EF. Central serotonin and impulsivr aggression. Br J Psychiatry. 1989:52–62. [PubMed] [Google Scholar]
  16. Consiglio AR, Bridges RS. Circulating prolactin, MPOA prolactin receptor expression and maternal aggression in lactating rats. Behav Brain Res. 2009;197:97–102. doi: 10.1016/j.bbr.2008.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Consiglio AR, Borsoi A, Pereira G, Lucion AB. Effects of oxytocin microinjected into different areas of the central nervous systemonmaternal aggressive behavior. Physiol Behav. 2005;85:354–362. doi: 10.1016/j.physbeh.2005.05.002. [DOI] [PubMed] [Google Scholar]
  18. Davidson RJ, Putnam KM, Larson C. Dysfunction in the neural circuitry of emotion regulation - a possible prelude to violence. Science. 2000;289:591–594. doi: 10.1126/science.289.5479.591. [DOI] [PubMed] [Google Scholar]
  19. De Almeida RMM, Lucion AB. Effects of intracerebroven-tricular administration of 5-HT receptor agonists on the maternal aggression of rats. Eur J Pharmacol. 1994;264:445–448. doi: 10.1016/0014-2999(94)00548-6. [DOI] [PubMed] [Google Scholar]
  20. De Almeida RMM, Lucion AB. 8-OH-DPAT in the median raphé, dorsal periaqueductal gray and corticomedial amygdale nucleus decreases, but the medial septal area it can increase maternal aggressive behavior in rats. Psychopharmacology. 1997;134:392–400. doi: 10.1007/s002130050476. [DOI] [PubMed] [Google Scholar]
  21. De Almeida RMM, Miczek KA. Aggression escalated by social instigation or by discontinuation of reinforcement (“frustration”) in mice: inhibition by anpirtoline - a 5-HT1B receptor agonist. Neuropsychopharmacology. 2002;272:171–181. doi: 10.1016/S0893-133X(02)00291-9. [DOI] [PubMed] [Google Scholar]
  22. De Almeida RMM, Faccidomo S, Fish E, Miczek KA. Inhibition of alcohol-heightened aggression by action at postsynaptic 5-HT1b receptors in male mice. Aggress Behav. 2001;3:234–235. [Google Scholar]
  23. De Almeida RMM, Santos DM, Saft DM, Benini Q, Miczek KA. 5-HT1B receptors, ventral orbitfrontal cortex, and aggressive behavior in mice. Psychopharmacology. 2006;185:441–450. doi: 10.1007/s00213-006-0333-3. [DOI] [PubMed] [Google Scholar]
  24. De Boer SF, Koolhaas JM. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol. 2005;523:125–139. doi: 10.1016/j.ejphar.2005.09.065. [DOI] [PubMed] [Google Scholar]
  25. De Boer SF, Lesourd M, Mocaer E, Koolhaas JM. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptaminelA receptors: a comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J Pharmacol Exp Ther. 1999;288:1125–1133. [PubMed] [Google Scholar]
  26. De Boer SF, Lesourd M, Mocaer E, Koolhaas JM. Somatoden-dritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptors agonist in rats: an ethopharmacological Psychopharmacology study with S-15535, alnespirone, and WAY-100635. Neuropsychopharmacology. 2000;23:20–33. doi: 10.1016/S0893-133X(00)00092-0. [DOI] [PubMed] [Google Scholar]
  27. De Castilhos J, Marcuzzo S, Forti CD, Frey R, Stein D, Achaval M, Rasia-Filho AA. Further studies on the rat posterodorsal medial amygdala: dendritic spine density and effect of 8-OH-DPAT microinjection on male sexual behavior. Brain Res Bull. 2006;69:131–139. doi: 10.1016/j.brainresbull.2005.11.013. [DOI] [PubMed] [Google Scholar]
  28. Descarries L, Watkins KC, Garcia S, Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J Comp Neurol. 1982;3:239–254. doi: 10.1002/cne.902070305. [DOI] [PubMed] [Google Scholar]
  29. Erskine MS, Barfield RJ, Goldman BD. Intraespecific figthing during late pregnancy and lactation in rats and effects of litter removal. Behav Biol. 1978;23:206–218. doi: 10.1016/s0091-6773(78)91814-x. [DOI] [PubMed] [Google Scholar]
  30. Factor EM, Mayer AD, Rosenblatt JS. Peripeduncular nucleus lesions in the rat: I. Effects on maternal aggression, lactation, and maternal behavior during pre- and postpartum periods. Behav Neurosci. 1993;107:166–185. doi: 10.1037//0735-7044.107.1.166. [DOI] [PubMed] [Google Scholar]
  31. Ferreira MD, Menescal-de-Oliveira L. Role of dorsal raphe nucleus 5-HT(1A) and 5-HT(2) receptors in tonic immobility modulation in guinea pigs. Brain Res. 2009;1285:69–76. doi: 10.1016/j.brainres.2009.06.030. [DOI] [PubMed] [Google Scholar]
  32. Ferreira A, Dahlof LG, Hansen S. Olfactory mechanisms in the control of maternal aggression, appetite, and fearfulness: effects of lesions to olfactory receptors, mediodorsal thalamic nucleus, and insular prefrontal cortex. Behav Neurosci. 1987;101:709–717. doi: 10.1037//0735-7044.101.5.709. see also p. 746. [DOI] [PubMed] [Google Scholar]
  33. Ferreira A, Picazo O, Uriarte N, Pereira M, Fernandez-Guasti A. Inhibitory effect of buspirone and diazepam, but not of 8-OH-DPAT, on maternal behavior and aggression. Pharmacol Biochem Behav. 2000;66:389–396. doi: 10.1016/s0091-3057(00)00211-2. [DOI] [PubMed] [Google Scholar]
  34. Fish EW, Faccidomo S, Miczek KA. Aggression heightened by alcohol or social instigation in mice: reduction by the 5-HT1B receptor agonist CP-94, 253. Psychopharmacology. 1999;146:391–399. doi: 10.1007/pl00005484. [DOI] [PubMed] [Google Scholar]
  35. Garattini S, Giacalone E, Valzelli L. Isolation, aggressiveness and brain 5-hydroxytryptamine turnover. J Pharm Pharmacol. 1967;19:338–339. doi: 10.1111/j.2042-7158.1967.tb08099.x. [DOI] [PubMed] [Google Scholar]
  36. Giacalone E, Tansella M, Valzelli L, Garattini S. Brain serotonin metabolism in isolated aggressive mice. Biochem Pharmacol. 1968;17:1315–1327. doi: 10.1016/0006-2952(68)90069-5. [DOI] [PubMed] [Google Scholar]
  37. Giovenardi M, Padoin MJ, Cadore LP, Lucion AB. Hypotha-lamic paraventricular nucleus modulates maternal aggression in rats: effects of ibotenic acid lesion and oxytocin antisense. Physiol Behav. 1998;63:351–359. doi: 10.1016/s0031-9384(97)00434-4. [DOI] [PubMed] [Google Scholar]
  38. Haney M, De Bold JF, Miczek KA. Maternal aggression in mice and rats toward male and female conspecifics. Aggress Behav. 1989;15:443–453. [Google Scholar]
  39. Hansen S, Ferreira A. Effects of bicuculline infusions in the ventromedial hypothalamus and amygdaloid complex on food intake and affective behavior in mother rats. Behav Neurosci. 1986;100:410–415. doi: 10.1037//0735-7044.100.3.410. [DOI] [PubMed] [Google Scholar]
  40. Hawkins KA, Trobst KK. Frontal lobe dysfunction and aggression: conceptual issues and research findings. Aggression Violent Behav. 1998;5:147–157. [Google Scholar]
  41. Hawkins KA, Trobst KK. Frontal lobe dysfunction and aggression: conceptual issues and research findings. Aggress Violent Behav. 2000;5:147–157. [Google Scholar]
  42. Insel TR. Postpartum increases in brain oxytocin binding. Neuroendocrinology. 1986;44:515–518. doi: 10.1159/000124694. [DOI] [PubMed] [Google Scholar]
  43. Jacobs BL, Azmitia EC. Structure and function of the brain serotonin system. Physiol Rev. 1992;1:165–229. doi: 10.1152/physrev.1992.72.1.165. [DOI] [PubMed] [Google Scholar]
  44. Joppa MA, Rowe RK, Meisel RL. Effects of serotonin 1A and 1B receptor agonists on social aggression in male and female syrian hamsters. Pharmacol Biochem Behav. 1997;58:349–353. doi: 10.1016/s0091-3057(97)00277-3. [DOI] [PubMed] [Google Scholar]
  45. Kheramin S, Body S, Herrera FM, Bradshaw CM, Szabadi E, Deakin JF, Anderson IM. The effect of orbital prefrontal cortex lesions on performance on a progressive ratio schedule: implications for models of inter-temporal choice. Behav Brain Res. 2005;156:145–152. doi: 10.1016/j.bbr.2004.05.017. [DOI] [PubMed] [Google Scholar]
  46. Kreiss DS, Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autorecep-tors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther. 1994;269:1268–1279. [PubMed] [Google Scholar]
  47. Lagerspetz KMJ, Hautojarvi S. The effect of prior aggressive or sexual arousal on subsequent aggressive or sexual reactions in male mice. Scand J Psychol. 1967;8:1–6. doi: 10.1111/j.1467-9450.1967.tb01365.x. [DOI] [PubMed] [Google Scholar]
  48. Lonstein JL, Gammie SC. Sensory, hormonal, and neural control of maternal aggression in laboratory rodents. Neurosci Biobehav Rev. 2002;26:869–888. doi: 10.1016/s0149-7634(02)00087-8. [DOI] [PubMed] [Google Scholar]
  49. Lopez-Mendoza D, Guilar-Bravo H, Swanson HH. Combined effects of Gepirone and (+) WAY 100135 on territorialaggression in mice. Pharmacol Biochem Behav. 1998;61:1–8. doi: 10.1016/s0091-3057(97)00563-7. [DOI] [PubMed] [Google Scholar]
  50. Maas JW. Neurochemical differences between two strains of mice. Science. 1962;137:621–622. doi: 10.1126/science.137.3530.621. [DOI] [PubMed] [Google Scholar]
  51. Miczek KA, Hussain S, Faccidomo S. Alcohol-heightened aggression in mice: attenuation by 5-HT1A receptor agonists. Psychopharmacology. 1998;139:160–168. doi: 10.1007/s002130050701. [DOI] [PubMed] [Google Scholar]
  52. Miczek KA, Fish EW, Bold JF, Almeida RMM. Social and neural determinantsof aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and γ-aminobutyric acid systems. Psychopharmacology. 2002;163:434–458. doi: 10.1007/s00213-002-1139-6. [DOI] [PubMed] [Google Scholar]
  53. Millan MJ, Hjorth S, Samanin R, Schreiber R, Jaffard R, De Ladonchamps B, Veiga S, Goument B, Peglion JL, SpeddingG M, Brocco M. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. J Pharmacol Exp Ther. 1997;282:148–161. [PubMed] [Google Scholar]
  54. Miquel MC, Doucet E, Riad M, Adrien J, Verge D, Hamon M. Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain. Brain Res Mol Brain Res. 1992;14:357–362. doi: 10.1016/0169-328x(92)90104-j. [DOI] [PubMed] [Google Scholar]
  55. Mos J, Olivier B. RO 15-1788 does not influence postpartum aggression in lactating female rats. Psychopharmacology. 1986;90:278–280. doi: 10.1007/BF00181259. [DOI] [PubMed] [Google Scholar]
  56. Mos J, Oliiver B, Poth M, Aken H. The effects of intraventricular administration of eltoprazine, 1-(3-trifluorome-thylphenyl) piperazine hydrochloride and 8-OH-DPAT on resident intruder aggression in the rat. Eur J Pharmacol. 1992;212:295–298. doi: 10.1016/0014-2999(92)90348-8. [DOI] [PubMed] [Google Scholar]
  57. Mos J, Olivier B, Poth M, Van Oorschot R, Van Aken H. The effects of dorsal raphe administration of eltoprazine TFMPP and 8-OH-DPAT on resident-intruder aggression in the rat. Eur J Pharmacol. 1993;238:411–415. doi: 10.1016/0014-2999(93)90877-k. [DOI] [PubMed] [Google Scholar]
  58. Nelson RJ, Trainor BC. Neural mechanisms of aggression. Nat Rev Neurosci. 2007;8(7):536–546. doi: 10.1038/nrn2174. [DOI] [PubMed] [Google Scholar]
  59. Neumann ID, Veenema AH, Beiderbeck DI. Aggression and Anxiety: Social Context and Neurobiological Links. Front Behav Neurosci. 2010;4:12. doi: 10.3389/fnbeh.2010.00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Olivier B, Mos J. Serenics and aggression. Stress Med. 1986;197:209. [Google Scholar]
  61. Olivier B, Van Oorschot R. 5-HT1B receptors and aggression: a review. Eur J Pharmacol. 2005;526:207–217. doi: 10.1016/j.ejphar.2005.09.066. [DOI] [PubMed] [Google Scholar]
  62. Olivier B, Mos J, van Oorschot R. Maternal aggression in rats: effects of chlordiazepoxide and fluprazine. Psychopharmacology. 1985;86:68–76. doi: 10.1007/BF00431686. [DOI] [PubMed] [Google Scholar]
  63. Olivier B, Mos J, van Oorschot R. Maternal aggression in rats: lack of interaction between chlordiazepoxide and fluprazine. Psychopharmacology. 1986;88:40–43. doi: 10.1007/BF00310510. [DOI] [PubMed] [Google Scholar]
  64. Olivier B, Mos J, Van Der Heyden J, Hartog J. Serotonergic modulation of social interaction in male mice. Psychopharma-cology. 1989a;97:154–156. doi: 10.1007/BF00442239. [DOI] [PubMed] [Google Scholar]
  65. Olivier B, Mos JM, Tulp M, Schipper J, Bevan P. Modulatory action of serotonin in aggressive behavior. In: Bevan P, Cools AR, Archer T, editors. Behavioral pharmacology of 5-HT. Hillsdale: Lawrence Erlbaum Assoc; 1989b. pp. 89–115. [Google Scholar]
  66. Olivier B, Mos J, Hartog J, Rasmussen DL. Serenics: a new class of drugs for putative selective treatment of pathological destructive behaviour. Drug News Persp. 1990a;3:261–271. [Google Scholar]
  67. Olivier B, Mos J, Rasmussen D. Behavioural pharmacology of the serenic eltoprazine. Rev Drug Metabol Drug Interact. 1990b;8:31–83. doi: 10.1515/dmdi.1990.8.1-2.31. [DOI] [PubMed] [Google Scholar]
  68. Oliver B, Mos J, Raghoebar M, De Koning P, Mak M. Serenics. Prog Drug Res. 1994;42:167–308. doi: 10.1007/978-3-0348-7153-2_6. [DOI] [PubMed] [Google Scholar]
  69. Olivier BJ, Van Oorschot R, Hen R. Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry. 1995;28:80–90. doi: 10.1055/s-2007-979624. [DOI] [PubMed] [Google Scholar]
  70. Padovan CM, Guimarães FS. Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats. Pharmacol Biochem Behav. 2004;77:15–19. doi: 10.1016/j.pbb.2003.09.015. [DOI] [PubMed] [Google Scholar]
  71. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press; 1998. [Google Scholar]
  72. Payne AP, Andrews MJ, Wilson CA. Housing, fighting and biogenic amines in the midbrain and hypothalamus of the golden hamster. In: Miczek KA, editor. Ethopharmacological aggression research. New York: Alan R. Liss; 1984. [PubMed] [Google Scholar]
  73. Potegal M. Attack priming and satiation in female golden hamsters: tests of some alternatives to the aggression arousal interpretation. Aggress Behav. 1991;17:327–335. [Google Scholar]
  74. Potegal M, Tenbrink L. Behavior of attack-primed and attack-satiated female golden hamsters (Mesocricetus auratus) J Comp Psychol. 1984;98:66–75. [Google Scholar]
  75. Roberts C, Price GW, Middlemiss DN. Ligands for the investigation of 5-HT autoreceptor function. Brain Res Bull. 2001;56:463–469. doi: 10.1016/s0361-9230(01)00628-1. [DOI] [PubMed] [Google Scholar]
  76. Russel JA, Leng G. Sex, parturition and motherhood without oxytocin? J Endocrinol. 1998;157:343–359. doi: 10.1677/joe.0.1570343. [DOI] [PubMed] [Google Scholar]
  77. Sanchez C, Hyttel J. Isolation-induced aggression in mice: effects of 5-HT uptake inhibitors and involvement of postsynap-tic 5-HT1A receptors. Eur J Pharmacol. 1994;264:241–247. doi: 10.1016/0014-2999(94)00470-6. [DOI] [PubMed] [Google Scholar]
  78. Sanchez C, Arnt J, Moltzen EK. The antiaggressive potency of (−)-penbutolol involves both 5-HT1A and 5-HT1B receptors and betaadrenoceptors. Eur J Pharmacol. 1996;297:1–8. doi: 10.1016/0014-2999(95)00727-x. [DOI] [PubMed] [Google Scholar]
  79. Séguin JR. Neurocognitive elements of antisocial behavior: relevance of an orbitofrontal cortex account. Brain Cogn. 2004;55:185–197. doi: 10.1016/S0278-2626(03)00273-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Sharp T, Bramwell SR, Grahame-Smith DG. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol. 1989;96:283–290. doi: 10.1111/j.1476-5381.1989.tb11815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Sijbesma H, Schipper J, De Kloet ER, Mos J, Van Aken H, Olivier B. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol Biochem Behav. 1991;38:447–458. doi: 10.1016/0091-3057(91)90305-l. [DOI] [PubMed] [Google Scholar]
  82. Sinton CM, Fallon SL. Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur J Pharmacol. 1988;157:173–181. doi: 10.1016/0014-2999(88)90380-9. [DOI] [PubMed] [Google Scholar]
  83. Sprouse JS, Aghajanian GK. Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol. 1986;128:295–298. doi: 10.1016/0014-2999(86)90782-x. [DOI] [PubMed] [Google Scholar]
  84. Sprouse JS, Aghajanian GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse. 1987;1:3–9. doi: 10.1002/syn.890010103. [DOI] [PubMed] [Google Scholar]
  85. Svare B. Maternal aggression: hormonal, genetic, and developmental determinants. In: Krasnegor NA, Bridges RS, editors. Mammalian parenting: biochemical, neurobiological and behavioral determinants. New York: Oxford UP; 1990. pp. 118–132. [Google Scholar]
  86. Tellegen A, Horn JM. Primary aggressive motivation in three inbread strain of mice. J Comp Physiol Psychol. 1972;78:297–304. doi: 10.1037/h0032192. [DOI] [PubMed] [Google Scholar]
  87. Valzelli L. Psychopharmacology of aggression: an overview. Int Pharmacopsychiatry. 1981;16:39–48. doi: 10.1159/000468473. [DOI] [PubMed] [Google Scholar]
  88. Vandermaelen CP, Matheson GK, Wilderman RC, Patterson LA. Inhibition of serotoninergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug. Eur J Pharmacol. 1986;129:123–130. doi: 10.1016/0014-2999(86)90343-2. [DOI] [PubMed] [Google Scholar]
  89. Van Erp AMM, Miczek KA. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J Neurosci. 2000;20:9320–9325. doi: 10.1523/JNEUROSCI.20-24-09320.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Veiga CP, Miczek KA, Lucion AB, De Almeida RMM. Effect of 5-HT1B receptor agonists injected into the prefrontal cortex on maternal aggression in rats. Braz J Med Biol Res. 2007;40:825–830. doi: 10.1590/s0100-879x2006005000113. [DOI] [PubMed] [Google Scholar]
  91. Veit R, Flor H, Michael ERB, Hermann C, Lotze M, Grodd W, Birbaumer N. Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett. 2002;328:233–236. doi: 10.1016/s0304-3940(02)00519-0. [DOI] [PubMed] [Google Scholar]
  92. Volavka J. Neurobiology of violence. Washington: American Psychiatric Press; 1995. [Google Scholar]
  93. Volavka J. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry. 2002;159:255–262. doi: 10.1176/appi.ajp.159.2.255. [DOI] [PubMed] [Google Scholar]
  94. White SM, Kucharik RF, Moyer JA. Effects of serotonergic agents on isolation-induced aggression. Pharmacol Biochem Behav. 1991;39:729–736. doi: 10.1016/0091-3057(91)90155-u. [DOI] [PubMed] [Google Scholar]

RESOURCES